Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000318306-15-000025
Filing Date
2015-05-13
Accepted
2015-05-13 20:18:47
Documents
1
Period of Report
2015-05-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5504
  Complete submission text file 0000318306-15-000025.txt   7206
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
PLASMATECH BIOPHARMACEUTICALS INC (Issuer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SCO SECURITIES LLC 1285 AVENUE OF THE AMERICAS 35TH FLOOR NEW YORK NY 10019
Business Address
Alvino Mark (Reporting) CIK: 0001356828 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15771 | Film No.: 15859960